CUSABIO Antibodies against Rare Species of E.coli

In the fields of life science research and biomedicine, Escherichia coli (E. coli), as a classic prokaryotic model organism, occupies a core position in basic biological research and biotechnological applications due to its clear genetic background, simple culture conditions, and rapid growth and reproduction. With mature gene editing technologies and a well-defined metabolic regulation network, E. coli serves as a vital tool for exploring the physiological mechanisms of prokaryotic cells, gene expression regulation, and post-translational modification of proteins. Additionally, E. coli plays a critical role in recombinant protein expression, vaccine development, and the construction of gene therapy vectors. From the industrial production of recombinant insulin to the mechanistic research of CRISPR-Cas systems, the applications of E. coli span multiple key aspects of modern biotechnology. Its unique biological characteristics endow it with broad application prospects in fields such as biomedicine, food industry, and synthetic biology. With the continuous innovation of synthetic biology and genetic engineering technologies, E. coli is expected to play a more important role in novel drug development, biological sensing, and environmental governance.

The Rare Species Antibody Series of CUSABIO – the exclusive campaign for E. coli antibodies is specially designed for researchers engaged in cutting-edge life science research, biopharmaceutical development, and food safety testing. We provide highly specific and sensitive antibody products to meet your needs in E. coli protein research, quality control of biological products, and pathogen detection.